Author

Seock Yong Kang

Observed name: Seock Kang

Observed institutions: Konkuk University, Daegu-Gyeongbuk Medical Innovation Foundation, Pusan National University

OpenAlex ID: A5068033934

Discovery of a potent dual ALK and EGFR T790M inhibitor

2017 · Jaebong Jang, Jung Beom Son, et al. · European Journal of Medicinal Chemistry · 48

Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome

2021 · So-mi Kang, Min-Ho Yoon, et al. · Communications Biology · 39

Dynamic resolution of α-halo chiral esters for the synthesis of 3-substituted piperazin-2-ones

2011 · Jung In Jang, Seock Yong Kang, et al. · Tetrahedron · 23

Discovery of Dipeptide‐Derived Catalysts for the Enantioselective Addition of Dimethylzinc to Aldehydes

2012 · Seock Yong Kang, Yong Sun Park · European Journal of Organic Chemistry · 10

Asymmetric Synthesis of 3,4,6‐Trisubstituted 2,5‐Diketopiperazines by Using Dynamic Kinetic Resolution of α‐Bromo Tertiary Acetamides

2014 · Jinho Baek, Seock Yong Kang, et al. · European Journal of Organic Chemistry · 8

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome

2021 · So-mi Kang, Min-Ho Yoon, et al. · Communications Biology · 4

Asymmetric Preparation of New N,N-Dialkyl-2-amino-1,1,2-triphenylethanol Catalysts and a Kinetic Resolution in the Addition of Diethylzinc to Flavene-3-carbaldehydes

2013 · Yong Park, Seock Kang, et al. · Synlett · 3

Dual Enantioselective Control using D‐phenylglycine‐L‐proline‐derived Catalysts for the Enantioselective Addition of Diethylzinc to Aldehyde

2015 · Seock Yong Kang, Yong Sun Park · Bulletin of the Korean Chemical Society · 2

Abstract 1967: IN-119873, the next-generation allosteric EGFR TKI, a potent and highly selective EGFR L858R for the treatment of osimertinib-resistant NSCLC

2024 · Jong Ryoul Choi, Daseul Yoon, et al. · Cancer Research · 1

Abstract 5477: Compound A, a fourth-generation allosteric inhibitor, a potent and highly selective EGFR with L858R activating and C797S resistance mutations for the treatment of NSCLC

2022 · Yeji Byeon, Seung Hee Jung, et al. · Cancer Research · 1

ChemInform Abstract: Dual Enantioselective Control Using D‐Phenylglycine‐L‐Proline‐Derived Catalysts for the Enantioselective Addition of Diethylzinc to Aldehyde.

2016 · Seock Yong Kang, Yong Sun Park · ChemInform

ChemInform Abstract: Asymmetric Preparation of New N,N‐Dialkyl‐2‐amino‐1,1,2‐triphenylethanol Catalysts and a Kinetic Resolution in the Addition of Diethylzinc to Flavene‐3‐carbaldehydes.

2013 · Seock Yong Kang, Jinho Baek, et al. · ChemInform

ChemInform Abstract: Discovery of Dipeptide‐Derived Catalysts for the Enantioselective Addition of Dimethylzinc to Aldehydes.

2012 · Seock Yong Kang, Yong Sun Park · ChemInform

ChemInform Abstract: Dynamic Resolution of α‐Halo Chiral Esters for the Synthesis of 3‐Substituted Piperazin‐2‐ones.

2011 · Jung In Jang, Seock Yong Kang, et al. · ChemInform

Works count: 15

Citation count: 139

H-index: 5

I10-index: 4